Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein–Barr virus and the gut–brain axis

K Hashimoto - Molecular Psychiatry, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a serious public …

Damage to endothelial barriers and its contribution to long COVID

X Wu, M Xiang, H Jing, C Wang, VA Novakovic, J Shi - Angiogenesis, 2024 - Springer
The world continues to contend with COVID-19, fueled by the emergence of viral variants. At
the same time, a subset of convalescent individuals continues to experience persistent and …

Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19

T Kusakabe, WY Lin, JG Cheong, G Singh… - Nature …, 2023 - nature.com
Gastrointestinal fungal dysbiosis is a hallmark of several diseases marked by systemic
immune activation. Whether persistent pathobiont colonization during immune alterations …

[HTML][HTML] Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review

VV Lupu, CM Ghiciuc, G Stefanescu… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Post-infectious irritable bowel syndrome (PI-IBS) is a particular type of IBS, with symptom
onset after an acute episode of infectious gastroenteritis. Despite infectious disease …

Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and …

D Zhang, S Weng, C Xia, Y Ren, Z Liu, Y Xu, X Yang… - BMC medicine, 2023 - Springer
Background Since the coronavirus disease 2019 (COVID-19) outbreak, many COVID-19
variants have emerged, causing several waves of pandemics and many infections. Long …

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial

RI Lau, Q Su, ISF Lau, JYL Ching… - The Lancet Infectious …, 2024 - thelancet.com
Background Post-acute COVID-19 syndrome (PACS) affects over 65 million individuals
worldwide but treatment options are scarce. We aimed to assess a synbiotic preparation …

Laboratory findings and biomarkers in Long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges

D Tsilingiris, NG Vallianou, I Karampela… - International Journal of …, 2023 - mdpi.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

M Wang, Y Zhang, C Li, W Chang, L Zhang - Frontiers in Immunology, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has posed a global health crisis. Increasing …

Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19

M Trøseid, JC Holter, K Holm, B Vestad, T Sazonova… - Critical Care, 2023 - Springer
Background Gut microbiota alterations have been reported in hospitalized COVID-19
patients, with reduced alpha diversity and altered microbiota composition related to …

Gut microbiota in COVID-19: new insights from inside

B Zhou, X Pang, J Wu, T Liu, B Wang, H Cao - Gut microbes, 2023 - Taylor & Francis
The epidemic of coronavirus disease-19 (COVID-19) has grown to be a global health threat.
Gastrointestinal symptoms are thought to be common clinical manifestations apart from a …